AXOCARE provides an evidence-generation platform that transforms fragmented health data into structured longitudinal evidence for reproducible real-world evidence (RWE) and health economics and outcomes research (HEOR). The platform emphasizes governed secondary use of data, maintaining visibility of context, provenance, and quality throughout the evidence pipeline. It is built for organizations requiring method-specific, scientifically reviewed evidence rather than autonomous clinical conclusions.
Funding
Funding not disclosed
Founders
Product
Problem
Healthcare organizations and life-science companies face fragmented health data that lacks the context, provenance, and quality needed to support credible secondary-use research. Access to data alone does not constitute evidence readiness, making reproducible real-world evidence (RWE) and health economics and outcomes research (HEOR) difficult to generate at scale.
Solution
AXOCARE builds evidence-generation infrastructure that transforms fragmented health data into structured longitudinal evidence, supporting reproducible RWE, HEOR, research, and market-access evidence generation. The platform provides a governed evidence foundation across five connected stages, from data intake through analysis, ensuring that evidence-ready real-world data is an intermediate state on the path to reproducibility. It is designed for governed secondary use, where evidence generation remains purpose- and method-specific, with human scientific review where required. The platform does not provide autonomous diagnosis, treatment recommendations, or regulatory conclusions, preserving scientific rigor and methodological discipline.
Target Audience
Primary customers are pharmaceutical and biotechnology companies, contract research organizations, hospitals and clinical centers, and academic research institutions that need governed, reproducible longitudinal evidence for RWE, HEOR, market access, and research purposes.
Features
- Five-stage governed evidence pipeline connecting data ingestion, structuring, quality assessment, analysis, and reproducibility
- Context-preserving architecture that maintains data provenance, quality metrics, and intended-use visibility across the evidence lifecycle
- Method-specific evidence generation with defined question, population, exposure, comparator, outcomes, temporal logic, and methodology
- Built-in human scientific review workflows for evidence validation and credibility
- Platform logic adapts across different institutional contexts, from pharma/biotech to CROs and hospitals